TSCA

March 8, 2022
EPA Publishes Final Scope of D4 Risk Evaluation, Seeks Comment on Draft Revision to PV29 Risk Determination
March 7, 2022
EPA Will Extend Compliance Dates for Articles Containing PIP (3:1)
March 1, 2022
EPA Holds Webinar on TSCA Requirements and PMN Process for Biofuels
January 24, 2022
EPA Requests Comment on Draft TSCA Screening Methodology to Evaluate Chemical Exposures and Risks to Fenceline Communities
January 3, 2022
Forecast for U.S. Federal and International Chemical Regulatory Policy 2022
December 30, 2021
EPA Publishes Draft Scope of the Risk Evaluation for Asbestos Part 2: Supplemental Evaluation Including Legacy Uses and Associated Disposals of Asbestos
December 29, 2021
Draft Revision to Risk Determination for HBCD Retains Finding of Unreasonable Risk of Injury
December 21, 2021
EPA Intends Draft TSCA Systematic Review Protocol to Strengthen Science Used in Chemical Risk Evaluations
December 9, 2021
EPA Publishes Updated NAMs Work Plan
December 8, 2021
House Subcommittees Hold Hearing on PFAS R&D
 < 1 2 3 4 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2022 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.